A recent study showed that in pancreatic cancer cells, metformin potentiates the anti-tumor activity of resveratrol by inhibiting vascular endothelial growth factor b (VEGF-B) signaling pathway [19]. Here, VEGFB is linked to familial pancreatic carcinoma.